• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

130
60
57
52
52

COUNTRY

44
37
12
6
6

PRICE

2,436
2,467
3,972
3,982

PUBLISHED

59
357
1,760
3,982

PRODUCT TYPE

3,857
125

Pharmaceuticals

(3,982 Products)

What are the latest products in the pipeline of the world’s leading drug companies? How are the pharmaceutical giants and key niche players performing financially – in terms of stock performance, share value, price ratios, etc.? What are the latest deals, alliances and agreements among drug developers and manufacturers? These are just some of the questions answered by the following extensive selection of in-depth pharmaceutical company profiles. Examine the market strategy, organisational structure and product range performance of the likes of Procter & Gamble, Merck & Co, Eli Lilly, Pfizer, GlaxoSmithKline, Novartis and Bayer Schering. Numerous SWOT (Strengths, Weaknesses, Opportunities and Threats) company reports are also listed. Show Less Read more

Detailed assessment of CIPLA in Indian Respiratory (Asthma & COPD) Market

Established in 1935, Cipla diversified into respiratory business segment in 1972 with launch of medicinal aerosols. At present, Cipla is one of the largest players in Indian respiratory market with...

March 2015
FROM

Assessment of Strategic Partnership between Roche & Emcure in India

Roche, one of the top 10 companies in global pharmaceutical market entered into collaboration with one of the leading Indian manufacturer Emcure Pharmaceuticals to manufacture few of its patented...

March 2015
FROM

Top Five Global Pharmaceutical Companies: Performance, Strategies and Competitive Analysis

The global pharmaceutical industry is expected to reach $1,241 billion by 2016, growing at a CAGR of 5 7% The fragmented market has observed some changes in the competitive landscape during the last...

December 2012
FROM

(AFFY)AFFYMAX INC - Quantitative Valuation Report

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Three models: Valuation Model, Forecast Model...

August 2015

(SCR)SIMCERE PHARMAC - Quantitative Valuation Report

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Three models: Valuation Model, Forecast Model...

August 2015

(RGDX)RESPONSE GENETC - Quantitative Valuation Report

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Three models: Valuation Model, Forecast Model...

August 2015

(SVNT)SAVIENT PHARM - Quantitative Valuation Report

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Three models: Valuation Model, Forecast Model...

August 2015

(ZLCS)ZALICUS INC - Quantitative Valuation Report

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Three models: Valuation Model, Forecast Model...

August 2015

(QCOR)QUESTCOR PHARMA - Quantitative Valuation Report

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Three models: Valuation Model, Forecast Model...

August 2015

(TSPT)TRANSCEPT PHARM - Quantitative Valuation Report

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Three models: Valuation Model, Forecast Model...

August 2015

(TSRX)TRIUS THERAPEUT - Quantitative Valuation Report

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Three models: Valuation Model, Forecast Model...

August 2015

(VPHM)VIROPHARMA - Quantitative Valuation Report

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Three models: Valuation Model, Forecast Model...

August 2015

(SIGA)SIGA TECH INC - Quantitative Valuation Report

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Three models: Valuation Model, Forecast Model...

August 2015

(SMA)SYMMETRY MEDICL - Quantitative Valuation Report

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Three models: Valuation Model, Forecast Model...

August 2015

(USNA)USANA HLTH SCI - Quantitative Valuation Report

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Three models: Valuation Model, Forecast Model...

August 2015

(WCRX)WARNER CHIL PLC - Quantitative Valuation Report

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Three models: Valuation Model, Forecast Model...

August 2015

Rating and Forecast Report PHARMACYCLICS

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Our three models: Valuation Model, Forecast Model...

August 2015

(NAVB)NAVIDEA BIOPHAR - Quantitative Valuation Report

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Three models: Valuation Model, Forecast Model...

August 2015

(HMA)HEALTH MGT ASSC - Quantitative Valuation Report

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Three models: Valuation Model, Forecast Model...

August 2015

(MAKO)MAKO SURGICAL - Quantitative Valuation Report

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and useful report available. Three models: Valuation Model, Forecast Model...

August 2015
Loading Indicator

Our Clients

Grifols, S.A. Takeda Pharmaceutical Company Limited Alexion Pharmaceuticals Teva Pharmaceutical Industries Ltd. Endo International Plc. Essilor International S.A.